2-(Trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hydrochloride

Catalog No.: 
ACEYKX745
CAS No.: 
911064-58-9
Molecular Formula: 
C7H9ClF3N3
Molecular Weight: 
227.62
2-(Trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$212.00In stockInquiry
1g97%$399.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hydrochloride
IUPAC Name2-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hydrochloride
MDL No.MFCD09999262
Molecular FormulaC7H9ClF3N3
Molecular Weight227.62
SMILESFC(C1=CN2C(CNCC2)=N1)(F)F.[H]Cl
InChI KeyWQJNJYFZTOYWPU-UHFFFAOYSA-N
SynonymIMidazo[1,2-a]pyrazine, 5,6,7,8-tetrahydro-2-(trifluoroMethyl)-,hydrochloride
CAS No.911064-58-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACEYKX745 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACEYKX745 route product structure diagram
    ACEYKX745911064-58-9In Stock
Inquiry

2. ACEYKX745 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEYKX745 route product structure diagram
    ACEYKX745911064-58-9In Stock
Inquiry

3. ACEYKX745 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEYKX745 route product structure diagram
    ACEYKX745911064-58-9In Stock
Inquiry

Comments (0)